Cargando…
Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells
BACKGROUND: Hepatocellular carcinoma (HCC) is a common and aggressive cancer, and the treatment options are limited for patients with advanced HCC. Bufalin, the major digoxin-like component of the traditional Chinese medicine Chansu, exhibits significant anti-tumor activities in many tumor cell line...
Autores principales: | Qiu, Dong-Ze, Zhang, Zhou-Ji, Wu, Wei-Zhong, Yang, Yun-Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723921/ https://www.ncbi.nlm.nih.gov/pubmed/23870199 http://dx.doi.org/10.1186/1472-6882-13-185 |
Ejemplares similares
-
Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude mice
por: Zhang, Zhou-Ji, et al.
Publicado: (2014) -
Chansu inhibits the expression of cortactin in colon cancer cell lines in vitro and in vivo
por: Li, Chun, et al.
Publicado: (2015) -
A research update on the antitumor effects of active components of Chinese medicine ChanSu
por: Jia, Jinhao, et al.
Publicado: (2022) -
The Research Progress of Bufalin in the Treatment of Hepatocellular Carcinoma
por: Jiang, Han-yu, et al.
Publicado: (2022) -
The Mechanisms of Chansu in Inducing Efficient Apoptosis in Colon Cancer Cells
por: Li, Chun, et al.
Publicado: (2013)